Newsroom | 63417 results

HYOGO, Japan--(BUSINESS WIRE)--Acumen exercised its option to develop, manufacture, & commercialize, on a global basis, up to two candidates for development in the treatment of AD....

PALO ALTO, Calif.--(BUSINESS WIRE)--Spot Biosystems launches with $40M financing and world-first non-viral delivery of full-length dystrophin in animal models and human patients with DMD...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--LNS Research names the 2026 World's Most Productive Companies, as new Industrial Productivity Index data shows a widening gap for manufacturers....

NEW YORK--(BUSINESS WIRE)--OptionMetrics announced the release of IvyDB Canada 5.0 with expanded high-quality historical options data and analytics for Canadian markets....

MORRISVILLE, N.C.--(BUSINESS WIRE)--Clinical data on Arrivo Bio’s RABI-767 program will be presented at the 58th European Pancreatic Club (EPC)/International Association of Pancreatology (IAP) Annual Meeting, taking place June 24–27, 2026 in Istanbul, Turkey. The presentation will highlight RABI-767, a small molecule pancreatic lipase inhibitor in development for patients with predicted severe acute pancreatitis (SAP). RABI-767 is designed to inhibit pancreatic lipase activity and interrupt the...

AUSTIN, Texas--(BUSINESS WIRE)--Paradromics Inc., a neurotechnology company that has developed the highest data-rate brain-computer interface (BCI) platform, announced today the completion of the first surgical implantation in the FDA-approved Connect-One Early Feasibility Study (EFS) at University of Michigan Health. The procedure was performed by Matthew Willsey, M.D., Ph.D., a neurosurgeon and biomedical engineer, with Aditya S. Pandey, M.D., and a multidisciplinary team of providers. The Co...

TORONTO & VANCOUVER, British Columbia--(BUSINESS WIRE)--Medventions, founded at Sunnybrook Research Institute, is a healthcare-based, medtech innovation fellowship program that targets clinical needs and nurtures Canada’s rising medtech talent base. During the Medventions Toronto Innovation Day on June 9, Co-founder and Co-director, Dr. Ahmed Nasef, announced the launch of the Medventions Mitacs Umbrella agreement. This Umbrella will support Medventions fellowship programs across Canada, includ...

NEW YORK--(BUSINESS WIRE)--National Cancer Center Welcomes Allison Betof-Warner, M.D., Ph.D., and Rizwan Romee, M.D., to Scientific Advisory Board...

COLLEGE PARK, Md.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), the world’s leading quantum platform company, today announced Clavis XG Multiplex, a new addition to the company’s Clavis XG Quantum Key Distribution (QKD) portfolio designed to make quantum security even more practical and deployable across metropolitan fiber networks. Within the space, the Clavis XG product line has a clear advantage in enterprise‑grade network integration, from form factor and maintenance to configuration and management....

NASHVILLE, Tenn.--(BUSINESS WIRE)--PhaseWell Research (“PhaseWell”), a multisite clinical research company, today announced its partnership with Latin Clinical Trial Center (“LCTC”) in San Juan, Puerto Rico. Led by founder and Principal Investigator Dr. Carlos A. Sariol and Site Leader Anmari Ferrer, LCTC is widely recognized as one of Puerto Rico’s foremost clinical research sites, with two decades of continuous operation and a track record spanning more than 85 clinical studies across Phase I...